Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
CJC-1295/Ipamorelin: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after CJC-1295/Ipamorelin therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to CJC-1295/Ipamorelin overviewDuring Treatment (5 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| IGF-1 | ↑ increases | Every 4 weeks |
| Fasting GH | ↑ increases | Every 4 weeks |
| Fasting Glucose | → normalizes | Every 8 weeks |
| HbA1c | → normalizes | Every 12 weeks |
| Lipid Panel | → normalizes | Every 12 weeks |